U.S.: DEA Approves PTSD Marijuana Study
By Derrick Stanley
The Drug Enforcement Agency has approved a study on the effect of medical marijuana on post traumatic stress disorder. It will be the first randomized, controlled research in the U.S. for PTSD that will use the actual plant, and not just oils or synthesized marijuana.
Multidisciplinary Association for Psychedelic Studies, or MAPS, say the DEA's approval gives researchers the OK to purchase marijuana for the study from the National Institute of Drug Abuse.
The group should begin recruiting and enrolling participants as early as June, MAPS spokesman Brad Burge said.
"The contract with the state of Colorado was signed on April 20 — an unofficial national holiday in some circles — meaning the funds are en route to MAPS. We are now preparing to place the order for the marijuana for the study," Burge said in an email to Military Times.
Colorado in 2014 awarded a $2 million grant to MAPS for the research and at the same time gave an additional $5.6 million to several other organizations to support medical marijuana studies.
The research first received approval in March 2014 from the Health and Human Services Department and was set to get underway at the University of Arizona and other locations within a year. But the program was delayed after the school terminated the contract of Dr. Sue Sisley, who was then the primary researcher on the program.
Marcel Bonn-Miller with the University of Pennsylvania Perelman School of Medicine is now overseeing the project, with Sisley running half the study in Arizona and Ryan Vandrey overseeing the other half at Johns Hopkins University in Baltimore, Maryland.
Work also will be conducted at the University of Colorado School of Medicine.
Participants will include 76 veterans who have treatment-resistant PTSD. The study will various strains of marijuana with different potencies for comparison purposes.
"This is a critical step in moving our botanical drug development program forward at the federal level to gather information on the dosing, risks, and benefits of smoked marijuana for PTSD symptoms," said Amy Emerson, director of clinical research for the MAPS Public Benefit Corporation.